| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454805 | Lung Cancer | 2015 | 9 Pages |
Abstract
In this review, we survey the existing roles of CT and MRI for the management of MPM, including the currently applied size measurement criteria for the assessment of treatment response. New functional imaging techniques, such as positron emission tomography (PET), diffusion-weighted MRI (DWI) and dynamic contrast-enhanced MRI (DCE-MRI) that may potentially improve the assessment of treatment response will be highlighted and discussed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lin Cheng, Nina Tunariu, David J. Collins, Matthew D. Blackledge, Angela M. Riddell, Martin O. Leach, Sanjay Popat, Dow-Mu Koh,